These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 110030)

  • 1. Synthesis and psychotropic activity of side-chain hydroxylated delta6-tetrahydrocannabinol metabolites.
    Ohlsson A; Agurell S; Leander K; Dahmén J; Edery H; Porath G; Levy S; Mechoulam R
    Acta Pharm Suec; 1979; 16(1):21-33. PubMed ID: 110030
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure-activity relationships in the tetrahydrocannabinol series. Modifications on the aromatic ring and it the side-chain.
    Edery H; Grunfeld Y; Porath G; Ben-Zvi Z; Shani A; Mechoulam R
    Arzneimittelforschung; 1972 Nov; 22(11):1995-2003. PubMed ID: 4633591
    [No Abstract]   [Full Text] [Related]  

  • 3. The importance of side-chain hydroxylated metabolites of delta6-tetrahydrocannabinol in rhesus monkey.
    Halldin M; Widman M; Martin B
    Acta Pharm Suec; 1979; 16(1):34-40. PubMed ID: 110031
    [No Abstract]   [Full Text] [Related]  

  • 4. Manipulation of the tetrahydrocannabinol side chain delineates agonists, partial agonists, and antagonists.
    Martin BR; Jefferson R; Winckler R; Wiley JL; Huffman JW; Crocker PJ; Saha B; Razdan RK
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1065-79. PubMed ID: 10454479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural modifications of the cannabinoid side chain towards C3-aryl and 1',1'-cycloalkyl-1'-cyano cannabinoids.
    Papahatjis DP; Nahmias VR; Andreou T; Fan P; Makriyannis A
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1616-20. PubMed ID: 16387492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of new psychotropic 2-imidazolidinones.
    Fontanella L; Corsico N; Diena A; Galliani G; Glässer A
    Farmaco Sci; 1981 Jan; 36(1):3-12. PubMed ID: 7202707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tetrahydrocannabinol derivatives, synthesis and pharmacological testing].
    Eiden F; Gerstlauer C; Buchhorn H
    Arch Pharm (Weinheim); 1983 Apr; 316(4):326-34. PubMed ID: 6307215
    [No Abstract]   [Full Text] [Related]  

  • 8. [Derivatives of 2,3,4,5,-tetrahydro-1H-pyrido-(3,2-b)azepine and 2,3,4,5-tetrahydro-1H-pyrido(2,3-b)azepine and their corresponding lactams. II. Synthesis and pharmacologic study of their psychotropic activity].
    Yanagida AJ; Gansser C; Leinot M; Labrid C; Busch N
    Farmaco Sci; 1979 Jan; 34(1):26-35. PubMed ID: 45265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of delta 9-tetrahydrocannabinol on the extinction of an adverse associative memory.
    Ashton JC; Smith PF; Darlington CL
    Pharmacology; 2008; 81(1):18-20. PubMed ID: 17726344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and pharmacological properties of new derivatives of 1-diphenylacetamide-2-butanol.
    Kolasa K; Kleinrok Z; Pietrasiewicz T; Czechowska G; Zejc A; Gajewczyk L
    Pol J Pharmacol Pharm; 1989; 41(5):475-81. PubMed ID: 2577062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and central nervous system activities of certain fluorine-containing 3-substituted indol-2-ones.
    Joshi KC; Patni R; Chand P; Sharma V; Bhattacharya SK; Rao YV
    Pharmazie; 1984 Mar; 39(3):153-5. PubMed ID: 6728885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An animal test model for evaluating drugs with anti-mass-psychotic activity].
    Lemmingson O; Lüllmann H; Prooter H; de Voss R
    Arzneimittelforschung; 1974 Dec; 24(12):2070-3. PubMed ID: 4480286
    [No Abstract]   [Full Text] [Related]  

  • 13. General pharmacological actions of some synthetic tetrahydrocannabinol derivatives.
    Hardman HF; Domino EF; Seevers MH
    Pharmacol Rev; 1971 Dec; 23(4):295-315. PubMed ID: 5002533
    [No Abstract]   [Full Text] [Related]  

  • 14. Studying the behavioral effects of drugs in group-living nonhuman primates.
    Smith EO; Byrd LD
    Prog Clin Biol Res; 1983; 131():1-31. PubMed ID: 6359168
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of psychotropic drugs administered to pregnant rats on the behaviour of the offspring.
    Leonard BE
    Neuropharmacology; 1981 Dec; 20(12B):1237-42. PubMed ID: 6119636
    [No Abstract]   [Full Text] [Related]  

  • 16. Great apes and rhesus monkeys as subjects for psychopharmacological studies of stimulants and depressants.
    Pieper WA
    Fed Proc; 1976 Sep; 35(11):2254-7. PubMed ID: 821785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluotracen: a tricyclic compound with the combined properties of antidepressants and antipsychotics in animals.
    Fowler PJ; Zirkle CL; Macko E; Setler PE; Sarau HM; Misher A; Tedeschi DH
    Arzneimittelforschung; 1977; 27(8):1589-95. PubMed ID: 410422
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychoactive drugs, animal ECoG and behaviour.
    Rougeul A
    Electroencephalogr Clin Neurophysiol Suppl; 1982; 36():559-65. PubMed ID: 6819126
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis and central pharmacological screening of new aminoalkoxy derivatives of coumarin and chromene.
    Suski S; Zawadowski T; Bogdal M; Przemyk B; Szafrański B
    Pol J Pharmacol Pharm; 1992; 44(5):475-85. PubMed ID: 1297112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioural activity in the monkey (Macaca mulatta) of the metabolites of diazepam in man [proceedings].
    Nicholson AN; Wright CM
    Br J Pharmacol; 1976 Jul; 57(3):429P. PubMed ID: 823999
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.